Search for tag: "acc18"

2 Media

02:22 ACC 2018: What are the takeaways of the ODYSSEY… ACC 2018: What are the takeaways of the ODYSSEY Outcomes Trial?	ACC 2018: What are the takeaways of the ODYSSEY Outcomes Trial? Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses the results the ODYSSEY trail looking at the PCSK9 inhibitor alirocumab in patients who had a prior acute coronary syndrome and were… heart disease clinical research pcsk9 odyssey ldl statin acc18 dr. nissen cleveland clinic From ConsultQD Live Admin 0 likes 15 plays
01:49 ACC 2018: Is Routine Use of Beta Blockers in… ACC 2018: Is Routine Use of Beta Blockers in Patients having Non Cardiac Surgery Beneficial?	ACC 2018: Is Routine Use of Beta Blockers in Patients having Non Cardiac Surgery Beneficial? Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses a study (POISE) presented at ACC looking at patients provided beta blockers prophylactically before non-cardiac surgery. … heart disease beta blocker metoprolol poise acc18 dr. nissen cleveland clinic From ConsultQD Live Admin 0 likes 22 plays

02:22

ACC 2018: What are the takeaways of the ODYSSEY…

ACC 2018: What are the takeaways of the ODYSSEY Outcomes Trial?

Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses the results the ODYSSEY trail looking at the PCSK9 inhibitor alirocumab in patients who had a prior acute coronary syndrome and were…

From ConsultQD Live Admin 0 likes 15 plays

01:49

ACC 2018: Is Routine Use of Beta Blockers in…

ACC 2018: Is Routine Use of Beta Blockers in Patients having Non Cardiac Surgery Beneficial?

Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses a study (POISE) presented at ACC looking at patients provided beta blockers prophylactically before non-cardiac surgery. …

From ConsultQD Live Admin 0 likes 22 plays